Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 47
Filtrar
Mais filtros

País/Região como assunto
Intervalo de ano de publicação
1.
Front Immunol ; 13: 1072996, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36713388

RESUMO

Introduction: The primo vascular system (PVS), an intensive network structure, has been claimed to be representative of the acupuncture meridian. Here, we explored the role of the PVS in local enteritis and its modification by acupuncture. Methods: Chronic cecitis in rabbits was induced by 2,4,6-trinitro-benzene-sulfonic acid (TNBS). The PVS on the cecum was visualized with trypan blue staining, and collected with the help of microsurgical forceps under an optical stereomicroscope. Results: The increased primo vessels (PVs) and primo nodes (PNs) of the PVS on the surface of the cecum were induced by local inflammation, which was positively correlated with the inflammatory cells in the cecal mucosa. Tandem mass tag (TMT) based proteomic analysis revealed that 110 differentiated proteins of the PVS existed between TNBS-treated and control rabbits; 65 proteins were upregulated, while 45 proteins were downregulated. These proteins were mainly enriched in inflammation- and immunity-related processes, such as inflammatory cell proliferation, antigen presentation, and cell adhesion in the proliferated PVS (data are available via ProteomeXchange with the identifiers PXD034280). Importantly, TNBS-induced cecitis, the proliferated PVS and inflammation response-related proteins (CD40, CD45, HLA-DRA1, LAMP1, JAGN1 and FGL1) in the PVS were alleviated or reversed by repetitive electroacupuncture (EA) stimulations. Conclusion: These results suggest that the proliferated PVS and its active inclusions were related to the inflammatory process, which was modified by EA. Our study provides a new avenue for further exploration of the mechanism by which EA exerts anti-inflammatory effects.


Assuntos
Eletroacupuntura , Enterite , Tiflite , Animais , Coelhos , Proteômica , Inflamação , Enterite/induzido quimicamente , Enterite/terapia
2.
Medicine (Baltimore) ; 100(21): e26014, 2021 May 28.
Artigo em Inglês | MEDLINE | ID: mdl-34032719

RESUMO

BACKGROUND: Radiation enteritis (RE) is a common complication that often occurs after radiotherapy for abdominal and pelvic malignancies. RE could influence patients' quality of life seriously and it is difficult to cure by conventional treatments. A lot of studies have revealed that the external treatment of traditional Chinese medicine (TCM) for RE is a safe and economical approach, but there is no relevant systematic review. The present study performed a systematic review and meta-analysis to compare TCM external treatment and conventional treatment for RE to evaluate the effectiveness and safety of external treatment of traditional Chinese medicine in the treatment of RE. METHODS: Cochrane Library, PubMed, Embase, China National Knowledge Infrastructure (CNKI), Wan-Fang database, VIP Chinese Science and Technique Journals Database, and the Chinese Biomedical Literature Database (CBM) were searched. The time of publication was limited from inception to April, 2021. Two reviewers independently searched for the selected articles and extract the data. The RevMan V.5.3 statistical software (Cochrane Collaboration) and Stata V.16.0 software were used to conduct the meta-analysis. RESULTS: We will show the results of this study in a peer-reviewed journal. CONCLUSION: This meta-analysis will provide reliable evidence for external treatment of TCM in the treatment of RE. INPLASY REGISTRATION NUMBER: INPLASY202140120.


Assuntos
Enterite/terapia , Medicina Tradicional Chinesa/métodos , Neoplasias/radioterapia , Qualidade de Vida , Lesões por Radiação/terapia , Enterite/diagnóstico , Enterite/etiologia , Enterite/psicologia , Humanos , Metanálise como Assunto , Lesões por Radiação/diagnóstico , Lesões por Radiação/etiologia , Lesões por Radiação/psicologia , Radioterapia/efeitos adversos , Ensaios Clínicos Controlados Aleatórios como Assunto , Revisões Sistemáticas como Assunto , Resultado do Tratamento
3.
Medicine (Baltimore) ; 100(16): e25593, 2021 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-33879721

RESUMO

BACKGROUND: To systematically evaluate the effectiveness and safety of traditional Chinese medicine preparation XPYEG combined with SBI and SBI alone in the treatment of REC, and to provide the reference in drugs for the clinical treatment of children with rotavirus enteritis. METHODS: Retrieving the English databases: PubMed, Cochrane Library and Embase; Chinese databases: CNKI, CBM and WANFANG Data. Retrieving a randomized controlled trial of XPYEG and SBI in the treatment of REC. The retrieval time is from the above database until September 2020. The retrieval strategy of combining free words and subject words is adopted, and the references included in the literature are searched manually in accordance with the literature studied in this paper and not included in the above database. Two researchers screen the literature according to the literature inclusion and exclusion criteria, extract valid data and evaluate the quality of the literature, and cross-check it. Using the RevMan 5.3 software to conduct the meta-analysis on the main outcome and secondary outcome indicators of the included literature, while assessing the evidence quality of included study. RESULTS: The effectiveness and safety of XPYEG and SBI in the treatment of REC are presented through the main and secondary outcome indicators. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/3QSZG. CONCLUSION: This study will conclude whether the combination of XPYEG and SBI is more effective than SBI alone in the treatment of REC, and whether the medication increases the risk of adverse reactions compared with single medication. ETHICS AND DISSEMINATION: This study does not involve the specific patients, and all research data comes from publicly available professional literature, so an ethics committee is not required to conduct an ethical review and approval of the study.


Assuntos
Medicamentos de Ervas Chinesas/administração & dosagem , Enterite/terapia , Probióticos/administração & dosagem , Infecções por Rotavirus/terapia , Saccharomyces boulardii , Pré-Escolar , Enterite/virologia , Feminino , Humanos , Lactente , Masculino , Metanálise como Assunto , Ensaios Clínicos Controlados Aleatórios como Assunto , Projetos de Pesquisa , Infecções por Rotavirus/virologia , Revisões Sistemáticas como Assunto , Resultado do Tratamento
4.
Probiotics Antimicrob Proteins ; 13(2): 356-366, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-32975724

RESUMO

Subclinical necrotic enteritis (SNE) is one of the serious threats to the poultry industry. Probiotics have been proven to exert beneficial effects in controlling SNE. However, their exact mechanisms have not been fully elucidated. Moreover, few studies have focused on their impact on microRNAs (miRNAs). Therefore, the present study aimed to explore the miRNA expression profiles in the ileum of broiler chickens during probiotic supplementation for controlling SNE. A total of 180 newly hatched male broilers were randomly allocated into three groups, including a negative control group, an SNE infection group, and a Bacillus licheniformis H2 pretreatment group. Illumina high-throughput sequencing was conducted to identify the miRNA expression of the three groups. Results showed that 628 miRNAs, including 582 known miRNAs and 46 novel miRNAs, were detected in the miRNA libraries. The target genes of 57 significantly differentially expressed miRNAs were predicted and annotated. Moreover, they were found to be partly enriched in pathways related to immunity and inflammation such as tumor necrosis factor receptor binding, immune response-regulating signaling pathway, Toll-like receptor 2 signaling pathway, interleukin-15 production, activation of NF-κB-inducing kinase activity, and MAP kinase tyrosine/serine/threonine phosphatase activity. Some of the target genes of 57 miRNAs were related to the MAPK signaling pathway. Furthermore, the expression of several miRNAs, which may be involved in the MAPK signaling pathway, was significantly affected by SNE induction and showed no significant difference in the presence of H2. All these findings provide comprehensive miRNA expression profiles of three different treatment groups. They further suggest that H2 could exert beneficial effects in controlling SNE through immune and inflammatory response associated with altered miRNA expression, such as the MAPK signaling pathway.


Assuntos
Bacillus licheniformis , Enterite , MicroRNAs , Doenças das Aves Domésticas/terapia , Probióticos/uso terapêutico , Animais , Galinhas , Suplementos Nutricionais , Enterite/terapia , Enterite/veterinária , Íleo , Masculino , MicroRNAs/genética
5.
Poult Sci ; 99(10): 4861-4873, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32988523

RESUMO

This study investigated the hypothesis that high dietary calcium (Ca) would stimulate necrotic enteritis (NE) and reduce performance, gut health, and nutrient digestibility, and if increased, phytase would reduce NE. Ross 308 male broilers (n = 768) were randomly distributed to 8 treatments in a factorial arrangement. Factors were NE challenge (no or yes), phytase level (500 or 1,500 FTU/kg using 500 FTU/kg matrix values), and Ca level (0.6 or 1.0% starter, 0.5 or 0.9% grower, 0.4 or 0.8% finisher) with the same level of available P (0.40 S, 0.35 G, and 0.35 F). There were 48 pens, 16 birds per pen and 6 replications. Half of the birds were challenged with Eimeria spp on day 9 and 108 CFU per mL of Clostridium perfringens strain EHE-NE18 on day 14 and 15. Gain was higher in birds fed high phytase on day 14 (P < 0.01), day 21 (P < 0.01), day 28 (P < 0.01), and day 35 (P < 0.01). Birds fed high phytase had greater livability on day 21 (P < 0.01). Ca was more digestible in high-Ca diets on day 16, and an NE × Ca interaction (P < 0.05) showed this effect to be more pronounced in unchallenged than in challenged birds. A challenge × Ca interaction for apparent ileal digestibility (AID) of crude protein (CP) (P < 0.05) indicated lower AID of CP in challenged birds fed high Ca. The challenge decreased AID of Ca (P < 0.01). Ca level had no impact on C. perfringens count, but it decreased Lactobacillus (P < 0.05) and Bifidobacteria (P < 0.05) populations in the ceca. High dietary Ca decreased feed conversion ratio. Overall (42 D), the highest WG was observed in unchallenged birds fed high Ca and high phytase with the lowest WG observed in NE-challenged birds fed low Ca and low phytase. The results suggest that full matrix values for high doses of phytase may be appropriate during NE challenge.


Assuntos
6-Fitase , Cálcio da Dieta , Infecções por Clostridium , Enterite , Microbioma Gastrointestinal , Doenças das Aves Domésticas , 6-Fitase/farmacologia , Ração Animal/análise , Fenômenos Fisiológicos da Nutrição Animal , Animais , Carga Bacteriana/veterinária , Cálcio da Dieta/farmacologia , Galinhas , Infecções por Clostridium/terapia , Infecções por Clostridium/veterinária , Dieta/veterinária , Suplementos Nutricionais/análise , Digestão/efeitos dos fármacos , Enterite/fisiopatologia , Enterite/terapia , Enterite/veterinária , Microbioma Gastrointestinal/efeitos dos fármacos , Concentração de Íons de Hidrogênio , Masculino , Doenças das Aves Domésticas/terapia
6.
Poult Sci ; 99(10): 4914-4928, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32988528

RESUMO

Calcium has the capacity to interact with phytate-P to form Ca-phytate complexes and decrease the ability of exogenous phytase to degrade phytic acid. This study investigated the hypothesis that high dietary Ca would impair gut permeability, phytate esters (inositol x-phosphate, IPx: IP3, IP4, IP5, and IP6) degradation, jejunal gene expression, and intestinal morphology. Ross 308 day-old male broilers (n = 768) were distributed into 48-floor pens each housing 16 birds in a factorial arrangement. Factors were NE challenge-no or yes; phytase level of 500 or 1,500 FTU/kg, and Ca level 0.6 or 1.0% starter, 0.5 or 0.9% grower, 0.4 or 0.8% finisher with available P in each phase. Challenged birds were gavaged with 3 field strains of Eimeria on day 9 and 108 CFU per mL of Clostridium perfringens Strain EHE-NE18 on day 14 and day 15. A phytase × Ca interaction was observed in the ileum for IP3 (P < 0.01), IP4 (P < 0.05), and IP6 (P < 0.01). The IP3 and IP4 concentrations were similar for both doses of phytase in the presence of low Ca, but with high Ca, both increased significantly but to a greater extent when the high dose of phytase was used. While IP6 concentrations were low and similar between both doses of phytase at low Ca levels, increasing dietary Ca levels increased IP6 concentrations regardless of phytase dose, but the effect was greater in the low phytase diet. A phytase × Ca interaction was detected for vitamin D receptor (VDR) (P < 0.05) expression where bird fed low phytase and low Ca recorded the highest expression of VDR, all other treatments being equivalent. The challenge decreased crypt depth to villus height ratio (P < 0.001). Challenge birds had higher fluorescein isothiocyanate dextran (P < 0.05) in blood compared with unchallenged birds. Thus, high Ca and high phytase, while not the best for IP6 destruction, did not lead to huge reductions in indicators of gut health.


Assuntos
6-Fitase , Cálcio da Dieta , Enterite , Ésteres , Microbioma Gastrointestinal , Expressão Gênica , Jejuno , 6-Fitase/farmacologia , Ração Animal/análise , Animais , Cálcio da Dieta/farmacologia , Galinhas/genética , Dieta/veterinária , Suplementos Nutricionais/análise , Enterite/terapia , Enterite/veterinária , Ésteres/análise , Ésteres/metabolismo , Microbioma Gastrointestinal/efeitos dos fármacos , Expressão Gênica/efeitos dos fármacos , Intestinos/efeitos dos fármacos , Jejuno/efeitos dos fármacos , Masculino , Permeabilidade/efeitos dos fármacos , Ácido Fítico/metabolismo
7.
Poult Sci ; 99(4): 2048-2060, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32241490

RESUMO

Necrotic enteritis (NE) is an infection of the gastrointestinal tract and is estimated to cost the global poultry industry billions of dollars annually. A study was conducted to examine whether reducing the crude protein might offset the severity of NE in broilers experimentally challenged with Eimeria spp. on day 9 and Clostridium perfringens on days 14 and 15. Furthermore, increasing the dietary amino acid (AA) density of the diet was also examined owing to identified benefits of improving performance compromised from low protein (LP) diets or NE. A 2 × 2 × 3 factorial arrangement of treatments at 6 replicates per treatment was used with 972 Ross 308 cockerels fed wheat-sorghum-soy-based diets to 35 D. Factors were NE challenge: no or yes; protein: standard (SP) or LP; and AA density: 100% AA, 115% with only essential AA (115% EAA) increased, and 115% AA with both essential and nonessential AA (115% AA) increased. The performance was measured in grower (days 7-21), finisher (days 21-35), and overall (day 7-35) periods. In addition, on day 16, intestinal lesion score and cecal short-chain fatty acids were measured. Only in nonchallenged birds fed LP diets, 115% AA increased grower feed intake (P < 0.01) and body weight gain (P < 0.05) compared to 115% EAA treatments. Challenge increased jejunal lesions (P < 0.001) with no difference between dietary treatments. Finisher body weight gain was greater in nonchallenged birds fed the 115% AA diets than in challenged birds (P < 0.05). Feeding diets with higher nonessential AA encouraged faster recovery from NE challenge. When fed the SP diets, NE challenge increased cecal butyric acid (P < 0.01) and total short-chain fatty acids (P < 0.05). The nutrient matrix used in LP diets does not favor beneficial butyric acid-producing bacteria. Using LP diets to mitigate NE severity does not offset the predisposing effect of E. spp. when attacking the gastrointestinal tract, and NE recovery is favored when feeding SP diets or additional AA.


Assuntos
Aminoácidos/metabolismo , Infecções por Clostridium/veterinária , Coccidiose/veterinária , Dieta com Restrição de Proteínas/veterinária , Enterite/veterinária , Doenças das Aves Domésticas/terapia , Aminoácidos/administração & dosagem , Ração Animal/análise , Animais , Infecções Assintomáticas , Galinhas , Infecções por Clostridium/microbiologia , Infecções por Clostridium/terapia , Clostridium perfringens/efeitos dos fármacos , Coccidiose/parasitologia , Coccidiose/terapia , Suplementos Nutricionais/análise , Relação Dose-Resposta a Droga , Eimeria/efeitos dos fármacos , Enterite/microbiologia , Enterite/parasitologia , Enterite/terapia , Necrose/microbiologia , Necrose/parasitologia , Necrose/terapia , Necrose/veterinária , Doenças das Aves Domésticas/microbiologia , Doenças das Aves Domésticas/parasitologia , Distribuição Aleatória
8.
Ann Allergy Asthma Immunol ; 124(3): 219-226, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31778820

RESUMO

OBJECTIVE: To review novel therapeutics in development for treatment of eosinophilic gastrointestinal disorders (EGIDs). DATA SOURCES: Clinical trial data (clinicaltrials.gov) and literature search on PubMed. STUDY SELECTIONS: Studies on treatment and clinical trials in EGIDs were included in this review. RESULTS: During the past decade, significant progress has been made in understanding disease mechanisms in EGIDs. As a result, a variety of novel therapeutics have been developed for treatment of these disorders. Several monoclonal antibodies against targets, including interleukin (IL) 4, IL-5, IL-13, integrins, and siglec-8, have shown promise in early trials. Novel formulations of corticosteroids are also in development. CONCLUSION: The field of EGID research has advanced rapidly, and disease-modifying therapeutics are closer to clinical application.


Assuntos
Enterite/terapia , Eosinofilia/terapia , Gastrite/terapia , Terapia Biológica , Biomarcadores , Ensaios Clínicos como Assunto , Terapia Combinada , Gerenciamento Clínico , Suscetibilidade a Doenças , Enterite/diagnóstico , Enterite/etiologia , Enterite/metabolismo , Eosinofilia/diagnóstico , Eosinofilia/etiologia , Eosinofilia/metabolismo , Gastrite/diagnóstico , Gastrite/etiologia , Gastrite/metabolismo , Humanos , Terapia de Alvo Molecular , Padrão de Cuidado , Resultado do Tratamento
9.
Clin Rev Allergy Immunol ; 57(2): 272-285, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30903439

RESUMO

Eosinophilic gastrointestinal disorders (EGID) are a group of disorders characterized by pathologic eosinophilic infiltration of the esophagus, stomach, small intestine, or colon leading to organ dysfunction and clinical symptoms (J Pediatr Gastroenterol Nutr; Spergel et al., 52: 300-306, 2011). These disorders include eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), eosinophilic gastroenteritis (EGE), eosinophilic enteritis (EE), and eosinophilic colitis (EC). Symptoms are dependent not only on the location (organ) as well as extent (layer invasion of the bowel wall). Common symptoms of EoE include dysphagia and food impaction in adults and heartburn, abdominal pain, and vomiting in children. Common symptoms of the other EGIDs include abdominal pain, nausea, vomiting, early satiety, diarrhea, and weight loss. These disorders are considered immune-mediated chronic inflammatory disorders with strong links to food allergen triggers. Treatment strategies focus on either medical or dietary therapy. These options include not only controlling symptoms and bowel inflammation but also on identifying potential food triggers. This chapter will focus on the clinical presentation, pathophysiology, and treatment of these increasingly recognized disorders.


Assuntos
Enterite/epidemiologia , Enterite/terapia , Eosinofilia/epidemiologia , Eosinofilia/terapia , Esofagite Eosinofílica/epidemiologia , Esofagite Eosinofílica/terapia , Gastrite/epidemiologia , Gastrite/terapia , Adolescente , Corticosteroides/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Terapia Biológica , Criança , Pré-Escolar , Dietoterapia , Enterite/diagnóstico , Enterite/fisiopatologia , Eosinofilia/diagnóstico , Eosinofilia/fisiopatologia , Esofagite Eosinofílica/diagnóstico , Esofagite Eosinofílica/fisiopatologia , Feminino , Gastrite/diagnóstico , Gastrite/fisiopatologia , Predisposição Genética para Doença , Humanos , Fatores Imunológicos/uso terapêutico , Lactente , Masculino , Pessoa de Meia-Idade , Inibidores da Bomba de Prótons/uso terapêutico , Fatores Sexuais , Adulto Jovem
10.
Sci Rep ; 8(1): 1744, 2018 01 29.
Artigo em Inglês | MEDLINE | ID: mdl-29379124

RESUMO

Necrotic enteritis (NE) is a severe intestinal disease, which can change gut microbiota and result in a high cost for the poultry industry worldwide. However, little is known regarding how the gut microbiota of NE chicken ileum are changed by Bacillus licheniformis. This study was conducted to investigate how ileum microbiota structure was changed by B. licheniformis in broiler chickens challenged with Clostridium perfringens-induced NE through Illumina MiSeq sequencing. The broilers were randomly separated into four groups: the negative control group (NC), the positive control group (PC), the fishmeal and coccidia group (FC), and the PC group supplied with feed containing B. licheniformis (BL). Compared to the PC and FC, alpha diversity, beta diversity, and the bacterial taxa of the ileum microbiota were more similar in BL and NC. Some genera, which were related to the NE control, became insignificant in BL with NC, such as Lactobacillus, Lactococcus, Bacteroides, Ruminococcus and Helicobacter. The PICRUSt analysis revealed that a tumour suppressor gene, p53, which was negatively correlated with Helicobacter, was enriched in the BL group. Our findings showed that the ileum microbiota disorder caused by NE in chickens was normalized by dietary B. licheniformis supplementation.


Assuntos
Bacillus licheniformis/crescimento & desenvolvimento , Infecções por Clostridium/veterinária , Disbiose , Enterite/veterinária , Microbioma Gastrointestinal , Íleo/microbiologia , Doenças das Aves Domésticas/microbiologia , Animais , Terapia Biológica/métodos , Galinhas , Infecções por Clostridium/complicações , Infecções por Clostridium/microbiologia , Infecções por Clostridium/terapia , Clostridium perfringens/crescimento & desenvolvimento , Dieta/métodos , Enterite/complicações , Enterite/microbiologia , Enterite/terapia , Metagenômica , Necrose/complicações , Necrose/microbiologia , Necrose/terapia , Necrose/veterinária , Análise de Sequência de DNA , Resultado do Tratamento
11.
Cancer Radiother ; 20(5): 416-21, 2016 Jul.
Artigo em Francês | MEDLINE | ID: mdl-27342943

RESUMO

Worldwide, more than a million people receive each year a curative radiotherapy. While local control and overall survival are steadily increasing, 5 to 15% of patients still develop above grade 2 late toxicities. Late toxicities treatments are complex. Hyperbaric oxygenation was shown to induce revascularization and healing of injured tissues, but indications are still debated. Through a literature review, we summarized the hyperbaric oxygenation indications in radiation-induced late toxicities. We also studied the knowledge and practice of French local radiation therapists. It seems that hyperbaric oxygen therapy can be a conservative treatment of haemorrhagic cystitis and radiation-induced pain, in case of drug therapies failure. Often associated with a significant morbidity and mortality, surgery could be avoided. The risk of complications in case of tooth extraction in irradiated tissues is also reduced. However, the role of hyperbaric oxygenation for mandibular osteoradionecrosis, radiation-induced proctitis, enteritis, lymphoedema, brachial plexopathy, skin and neurological sequelae seems more questionable since studies results are conflicting. Future outcomes of phase III studies are expected to clarify the role of hyperbaric oxygenation in the management of radio-induced toxicities, including for head and necks complications.


Assuntos
Oxigenoterapia Hiperbárica , Radioterapia/efeitos adversos , Neuropatias do Plexo Braquial/etiologia , Neuropatias do Plexo Braquial/terapia , Transtornos Cognitivos/etiologia , Transtornos Cognitivos/terapia , Cistite/terapia , Enterite/etiologia , Enterite/terapia , Humanos , Linfedema/etiologia , Linfedema/terapia , Doenças Mandibulares/terapia , Osteorradionecrose/terapia , Proctite/etiologia , Proctite/terapia , Radiodermite/terapia , Extração Dentária
12.
Nutr Hosp ; 32(6): 2446-59, 2015 Dec 01.
Artigo em Espanhol | MEDLINE | ID: mdl-26667691

RESUMO

INTRODUCTION: nutrition is an important influence on treatments and quality of life of cancer patients. The relationship between different nutritional components and radiotherapy is today a topic of growing interest. OBJECTIVE: to evaluate the influence of macro and micronutrients on tolerance and effectiveness of radiotherapy and their role in modulating chronic toxicity. MATERIALS AND METHODS: we performed a research of the published literature by consulting the MEDLINE database and Cochrane Library online between 1995 and 2015, relevant publications based on impact factor were selected. Data from the analyzed studies were exposed in sections by type of nutrient. RESULTS: most of the studies showed common features: small sample sizes, high heterogeneity, underpowered results and few prospective randomized studies. In the section of fiber, its use in prophylaxis and treatment of radiation enteritis has been successfully evaluated in some studies, although evidence of its recommendation is still weak. Omega 3 and omega 6 fatty acids have a high metabolic potential, however the evidence regarding this benefit is limited to observational studies in certain tumors. Among the amino acids, glutamine is the most studied, and controversial results of its effect on mucositis, esophagitis and radiation enteritis were found. Vitamins and minerals are a heterogeneous group of substances that showed potential benefit due to their antioxidant activity and their supposed protector effect against toxicity secondary to radiotherapy. Ketogenic diets are beginning to be clinically studied after promising preclinical results. CONCLUSIONS: the analyzed studies show controversial or inconclusive results regarding the influence of nutrients in the radiotherapy. It has been not found Sorong evidence about their role in patients receiving ionizing radiation. Well-designed, prospective and randomized studies are needed to establish recommendations.


Introducción: la nutrición ejerce una importante influencia sobre los tratamientos y la calidad de vida del paciente oncológico. En la actualidad, la relación de los distintos componentes nutricionales con el tratamiento radioterápico es un tema de creciente interés. Objetivos: evaluar la posible influencia de los macro y micronutrientes sobre la tolerancia y eficacia del tratamiento radioterápico, así como su papel en la modulación de la toxicidad crónica. Material y métodos: se ha realizado una revisión bibliográfica consultando las bases de datos MEDLINE y Biblioteca Cochrane online entre los años 2000 y 2015, seleccionando los trabajos más relevantes según factor de impacto. Los datos obtenidos de los estudios analizados se han expuesto por apartados según el tipo de nutriente. Resultados: la mayoría de los estudios analizados presentan características comunes: pequeños tamaños muestrales, alta heterogeneidad en estudios de un mismo tema, escaso poder estadístico, pocos estudios prospectivos y aleatorizados. En el apartado de la fibra, su empleo como profilaxis y tratamiento de la enteritis rádica ha sido evaluado con resultados satisfactorios en algunos estudios, aunque la evidencia de su recomendación es todavía débil. Los ácidos grasos omega­3 y omega­6 tienen una gran potencialidad metabólica, aunque la evidencia de su beneficio se limita a estudios observacionales en determinados tumores. Entre los aminoácidos, la glutamina es el más estudiado, con resultados contradictorios en el aporte de beneficio en la mucositis oral, la esofagitis y la enteritis rádica. Las vitaminas y minerales constituyen un grupo heterogéneo de sustancias con beneficio potencial por su actividad antioxidante y su posible efecto protector, disminuyendo la toxicidad producida por la radioterapia. Las dietas cetogénicas están comenzando a estudiarse clínicamente después de los prometedores resultados preclínicos. Conclusiones: los estudios analizados muestran resultados contradictorios o poco concluyentes respecto a la influencia de los nutrientes en el tratamiento radioterápico. No se pueden establecer en la actualidadrecomen daciones claras sobre su papel. Son necesarios estudios prospectivos y aleatorizados, bien diseñados, para poder establecer recomendaciones.


Assuntos
Terapia Nutricional , Apoio Nutricional , Radioterapia/efeitos adversos , Radioterapia/métodos , Enterite/etiologia , Enterite/terapia , Humanos
14.
World J Gastroenterol ; 20(43): 16368-71, 2014 Nov 21.
Artigo em Inglês | MEDLINE | ID: mdl-25473198

RESUMO

Eosinophilic gastroenteritis is a rare disease of unknown etiology. It is characterized by patchy or diffuse eosinophilic infiltration of the bowel wall to a variable depth and various gastrointestinal manifestations. We describe a case of severe eosinophilic gastroenteritis presenting as frequent bowel obstruction and diarrhea in a 35-year-old man. The patient was misdiagnosed and underwent surgery because of intestinal obstruction when he was first admitted to a local hospital. Then he was misdiagnosed as having Crohn's disease in another university teaching hospital. Finally, the patient asked for further treatment from our hospital because of the on-going clinical trial for treating refractory Crohn's disease by fecal microbiota transplantation. Physical examination revealed a slight distended abdomen with diffuse tenderness. Laboratory investigation showed the total number of normal leukocytes with neutrophilia as 90.5%, as well as eosinopenia, monocytopenia and lymphocytopenia. Barium radiography and sigmoidoscopy confirmed inflammatory stenosis of the sigmoid colon. We diagnosed the patient as having eosinophilic gastroenteritis by multi-examinations. The patient was treated by fecal microbiota transplantation combined with oral prednisone, and was free from gastrointestinal symptoms at the time when we reported his disease. This case highlights the importance of awareness of manifestations of a rare disease like eosinophilic gastroenteritis.


Assuntos
Terapia Biológica/métodos , Erros de Diagnóstico , Enterite/terapia , Eosinofilia/terapia , Fezes/microbiologia , Gastrite/terapia , Glucocorticoides/uso terapêutico , Prednisona/uso terapêutico , Adulto , Biópsia , Colonoscopia , Meios de Contraste , Enterite/complicações , Enterite/diagnóstico , Enterite/microbiologia , Eosinofilia/complicações , Eosinofilia/diagnóstico , Eosinofilia/microbiologia , Gastrite/complicações , Gastrite/diagnóstico , Gastrite/microbiologia , Humanos , Masculino , Valor Preditivo dos Testes , Resultado do Tratamento
15.
Cell Biochem Biophys ; 69(2): 357-61, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24366547

RESUMO

The aim of the study was to investigate the effect of microbial immune enteral nutrition by microecopharmaceutics and deep sea fish oil and glutamine and Peptisorb on the patients with acute radiation enteritis in bowel function and immune status. From June 2010 to January 2013, 46 acute radiation enteritis patients in Liaocheng People's Hospital were randomized into the microbial immune enteral nutrition group and the control group: 24 patients in treatment group and 22 patients in control group. The immune microbial nutrition was given to the study group, but not to the control group. The concentration of serum albumin and prealbumin and the number of CD3 (+) T cell, CD4 (+) T cell, CD8 (+) T cell, CD4 (+)/CD8 (+) and natural killer cell of the two groups were detected on the 1, 7 and 14 days after treatment. The arm muscle circumference and triceps skinfold thickness (TSF) were recorded, and the tolerance of the two groups for enteral nutrition and intestinal symptoms was collected and then comparing the two indicators and get results. The tolerance of microbial immune enteral nutrition group about abdominal pain, bloating and diarrhea was better than the control group (P values were 0.018, 0.04 and 0.008 after 7 days; P values were 0.018, 0.015 and 0.002 after 14 days); and the cellular immune parameters were better than the control group((△) P = 0.008,([Symbol: see text]) P = 0.039, (☆) P = 0.032); No difference was found in nutrition indicators. To the patients with acute radiation enteritis, microbial immune enteral nutrition could improve the patient's immune status, and the tolerance of enteral nutrition could be better for the bowel function and the patients' rehabilitation.


Assuntos
Nutrição Enteral , Enterite/terapia , Probióticos/uso terapêutico , Doença Aguda , Idoso , Linfócitos T CD4-Positivos/citologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/citologia , Linfócitos T CD8-Positivos/imunologia , Calcitonina/sangue , Cromatografia Líquida de Alta Pressão , Enterite/patologia , Feminino , Óleos de Peixe/uso terapêutico , Glutamina/uso terapêutico , Humanos , Células Matadoras Naturais/citologia , Células Matadoras Naturais/imunologia , Lactulose/urina , Masculino , Manitol/urina , Pessoa de Meia-Idade , Neoplasias/radioterapia , Estado Nutricional , Pré-Albumina/análise , Precursores de Proteínas/sangue , Albumina Sérica/análise
16.
Diagn Pathol ; 8: 150, 2013 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-24041405

RESUMO

A 36-year-old female was hospitalized with symptoms suggesting intestinal occlusion. She was diagnosed with adenocarcinoma of the ampulla of Vater (pT4N0 stage) and underwent cephalic duodenopancreatectomy 8 months ago. Five cycles of postoperative chemotherapy were administrated using capecitabine and oxaliplatin (CAPOX or XELOX), the last one being completed 1 month ago. During the present hospitalization, because of normal computed tomography and ultrasound abdominal examination, rehydration and antibiotherapy were administrated. However, 4 days after hospital admission, the patient died. At autopsy and histological examination, we found a severe myocardial sclerosis with large scarring areas, severe steatohepatitis, chronic pancreatitis with large fibrotic areas, and acute enteritis. Alcohol consumption was denied. The patient died due to associated heart, liver and pancreatic failure. This multiorgan toxicity and death following CAPOX regimen had not yet been reported in the literature. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/6472150549833105.


Assuntos
Adenocarcinoma/tratamento farmacológico , Ampola Hepatopancreática/efeitos dos fármacos , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Neoplasias do Ducto Colédoco/tratamento farmacológico , Enterite/induzido quimicamente , Fígado Gorduroso/induzido quimicamente , Cardiopatias/induzido quimicamente , Pancreatite Crônica/induzido quimicamente , Doença Aguda , Adenocarcinoma/patologia , Adenocarcinoma/cirurgia , Adulto , Ampola Hepatopancreática/patologia , Ampola Hepatopancreática/cirurgia , Autopsia , Capecitabina , Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Doença Hepática Induzida por Substâncias e Drogas/terapia , Quimioterapia Adjuvante , Neoplasias do Ducto Colédoco/patologia , Neoplasias do Ducto Colédoco/cirurgia , Desoxicitidina/efeitos adversos , Desoxicitidina/análogos & derivados , Enterite/diagnóstico , Enterite/terapia , Evolução Fatal , Fígado Gorduroso/diagnóstico , Fígado Gorduroso/terapia , Feminino , Fluoruracila/efeitos adversos , Fluoruracila/análogos & derivados , Cardiopatias/diagnóstico , Cardiopatias/terapia , Humanos , Insuficiência de Múltiplos Órgãos/induzido quimicamente , Estadiamento de Neoplasias , Compostos Organoplatínicos/efeitos adversos , Oxaliplatina , Oxaloacetatos , Pancreaticoduodenectomia , Pancreatite Crônica/diagnóstico , Pancreatite Crônica/terapia
17.
Curr Opin Microbiol ; 16(5): 596-601, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23866975

RESUMO

Faecal microbiota transplantation (FMT) has been used for more than five decades to treat a variety of intestinal diseases associated with pathological imbalances within the resident microbiota, termed dysbiosis. FMT has been particularly effective for treating patients with recurrent Clostridium difficile infection who are left with few clinical options other than continued antibiotic therapy. Our increasing knowledge of the structure and function of the human intestinal microbiota and C. difficile pathogenesis has led to the understanding that FMT promotes intestinal ecological restoration and highlights the microbiota as a viable therapeutic target. However, the use of undefined faecal samples creates a barrier for widespread clinical use because of safety and aesthetic issues. An emerging concept of bacteriotherapy, the therapeutic use of a defined mixture of harmless, health-associated bacteria, holds promise for the treatment of patients with severe C. difficile infection, and possibly represents a paradigm shift for the treatment of diseases linked to intestinal dysbiosis.


Assuntos
Terapia Biológica/métodos , Clostridioides difficile/crescimento & desenvolvimento , Infecções por Clostridium/terapia , Disbiose/terapia , Enterite/terapia , Terapia Biológica/efeitos adversos , Humanos
19.
Poult Sci ; 91(4): 837-43, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22399722

RESUMO

Necrotic enteritis caused by Clostridium perfringens leads to serious economical losses to the poultry industry. There is a growing need to find effective, nontoxic, antibiotic alternatives to prevent and cure the disease. In our study, the efficacy of protected sodium butyrate at 1.5 g/kg (BP70), a Bacillus amyloliquefaciens spore suspension with 10(9) cfu/g (BAL; Ecobiol), a protected blend of essential oils (1%) at 1.5 g/kg (EO), and a combination of sodium butyrate with essential oils (1%) protected with vegetable fat at 1.5 g/kg (BP70+EO; Natesse) was investigated in an artifical C. perfringens-infection model. Body weight gain, gross pathological and histopathological lesion scores, villus lengths, and villus length:crypt depth ratio was determined and compared with the control group. Broilers infected with C. perfringens and treated with essential oils or the combination of sodium butyrate and essential oils showed significantly better BW gain (P < 0.05), increased villus length and villus length:crypt depth ratio (P < 0.001), and decreased gross pathological and histopathological lesion scores (P < 0.05) compared with the control. Sodium butyrate alone and B. amyloliquefaciens spore suspension had no beneficial effects on the course of the disease in this study. According to our results, the protected combination of sodium butyrate and essential oils, as well as the protected essential oils, can be potential candidates for the prevention and treatment of necrotic enteritis in broiler chickens.


Assuntos
Antibacterianos/uso terapêutico , Bacillus , Galinhas , Infecções por Clostridium/veterinária , Clostridium perfringens/efeitos dos fármacos , Enterite/veterinária , Doenças das Aves Domésticas/terapia , Esporos Bacterianos , Animais , Ácido Butírico/uso terapêutico , Infecções por Clostridium/tratamento farmacológico , Infecções por Clostridium/patologia , Infecções por Clostridium/terapia , Enterite/tratamento farmacológico , Enterite/patologia , Enterite/terapia , Intestino Delgado/patologia , Fígado/patologia , Óleos Voláteis/uso terapêutico , Doenças das Aves Domésticas/tratamento farmacológico , Doenças das Aves Domésticas/patologia , Aumento de Peso
20.
Undersea Hyperb Med ; 39(6): 1121-39, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23342770

RESUMO

Informal surveys at CME meetings have shown that approximately one-third of patients in the United States receive hyperbaric oxygen (HBO2) for delayed radiation injury. More than 600,000 patients receive radiation for malignancy in our country annually, and about one-half will be long-term survivors. Serious radiation complications occur in 5-10% of survivors. A large population of patients is therefore at risk for radiation injury. HBO2 has been applied to treat patients with radiation injury since the mid-1970s. Published results are consistently positive, but the level of evidence for individual publications is usually not high level, consisting mostly of case series and case reports. Only a rare randomized controlled trial has been accomplished. Radiation injury is one of the UHMS "approved" indications, and third-party payors will usually reimburse for this application. This updated review summarizes the publications available reporting results in treating radiation-injured patients. Mechanisms of HBO2 in radiation injury are discussed briefly. Outcome is reported on a mostly anatomic basis though due to the nature of the injury a positive outcome at one anatomic site is supportive of HBO2 at other sites. The potential benefit of prophylactic HBO2 before frank damage is also discussed in high-risk patients. The concerns of HBO2 enhancing growth of or precipitating recurrence of malignancy is discussed and largely refuted.


Assuntos
Tecido Conjuntivo/efeitos da radiação , Oxigenoterapia Hiperbárica/métodos , Osteorradionecrose/terapia , Lesões por Radiação/terapia , Abdome/patologia , Abdome/efeitos da radiação , Tecido Conjuntivo/patologia , Cistite/etiologia , Cistite/terapia , Enterite/etiologia , Enterite/terapia , Extremidades/patologia , Extremidades/efeitos da radiação , Humanos , Oxigenoterapia Hiperbárica/efeitos adversos , Laringe/patologia , Laringe/efeitos da radiação , Mandíbula/patologia , Mandíbula/efeitos da radiação , Necrose/patologia , Necrose/terapia , Sistema Nervoso/patologia , Sistema Nervoso/efeitos da radiação , Osteorradionecrose/patologia , Pelve/patologia , Pelve/efeitos da radiação , Proctite/etiologia , Proctite/terapia , Lesões por Radiação/patologia , Lesões por Radiação/prevenção & controle , Parede Torácica/patologia , Parede Torácica/efeitos da radiação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA